Protaryx Medical

Protaryx Medical is a Health Care startup that has made waves with its groundbreaking Protaryx Transseptal Access Device, which offers efficient access to the left side of the heart through the fossa ovalis. The device's standout feature is its integration of access and transseptal crossing functions into a single, versatile tool that can be used independently or alongside other therapy devices. This innovative approach is aimed at optimizing workflow efficiency and improving patient outcomes.

Founded in 2019 and headquartered in the United States, Protaryx Medical secured a significant $5.10M Series A investment on 30 June 2020, with backing from Ajax Health and UM Ventures. This investment not only signals confidence from established players in the healthcare industry but also provides the capital necessary for Protaryx Medical to further develop and commercialize its pioneering medical technology. With its clear focus on addressing a critical need in the healthcare sector, Protaryx Medical is poised to make a meaningful impact in the field of cardiac care and is a company worth tracking in the coming years.